Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

23.4%

11 terminated/withdrawn out of 47 trials

Success Rate

71.1%

-15.6% vs industry average

Late-Stage Pipeline

6%

3 trials in Phase 3/4

Results Transparency

0%

0 of 27 completed trials have results

Key Signals

2 recruiting10 terminated

Enrollment reporting

Analytics

N/A
22(68.8%)
Phase 2
7(21.9%)
Phase 3
2(6.3%)
Phase 4
1(3.1%)
32Total
N/A(22)
Phase 2(7)
Phase 3(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (47)

Showing 20 of 47 trials
NCT03439371Not ApplicableTerminated

Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia

Role: collaborator

NCT05130138Not ApplicableRecruiting

Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid Leukemia

Role: collaborator

NCT00333099Phase 4Completed

INEC Study: Immuno-modulating Enteral Nutrition in Cancer

Role: collaborator

NCT05091684Phase 2Terminated

Administration of Fibrinogen Concentrate for Refractory Bleeding

Role: collaborator

NCT03753776Phase 3Completed

Phase III Trial Evaluating Radium Bromatum Homeopathic Treatment Efficacy on Radiodermatitis Prevention and Treatment for Breast Cancer Women

Role: collaborator

NCT04517656Not ApplicableRecruiting

Biomarkers Impact Evaluation on the Post-transplant Immune Response After Allografting of Hematopoietic Stem Cells

Role: collaborator

NCT04250805Phase 2Terminated

Trial Evaluating the Efficacy of the Combination of ROpivacaine With Reference XYlocaine in the Evaluation of Pain During the Installation of Percutaneous Radiological GASTrostomy

Role: collaborator

NCT03233074Terminated

Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors

Role: collaborator

NCT03234335Completed

High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal Impairment

Role: collaborator

NCT03240341Not ApplicableCompleted

Influence of PARAmedical Interventions on Patient ACTivation in the Cancer Care Pathway

Role: collaborator

NCT03801122Phase 2Completed

Evolution of Thromboelastography During Tranexamic Acid Treatment

Role: collaborator

NCT04103359Not ApplicableTerminated

Comparison of Lower-risk MDS Patients With and Without Improvements in Fatigue Following Blood Transfusion Therapy

Role: collaborator

NCT02994914Not ApplicableTerminated

GEriatric Determinants of Curative RAdiotherapy Scheme Choice for Breast Cancer ELderly Patient Treatment Compliance and Tolerance

Role: collaborator

NCT02999152Not ApplicableTerminated

Validation of Radio-induced Damage Biomarkers

Role: collaborator

NCT03126045Not ApplicableCompleted

A Randomized Study Evaluating the Incidence of Post Lumbar Puncture Headache With Atraumatic Needles in Hematology

Role: collaborator

NCT03317613Phase 2Completed

Clinical Trial Assessing the Efficacy of Capsaicin Patch (Qutenza®) in Cancer Patients With Neuropathic Pain

Role: collaborator

NCT03324958Not ApplicableTerminated

VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients.

Role: collaborator

NCT03707301Terminated

Post-SOPHrology Cancer Patients' anxieTY Report

Role: collaborator

NCT03743961Terminated

Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic Neoplasia

Role: lead

NCT03323424Phase 2Withdrawn

Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers

Role: lead